Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABSW
- CUSIP Number: 78397t111
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 63k | $1.5k | 0% | Sep 2025 |
|
| Gts Securities | 41k | $1.0k | 100% | Dec 2025 |
|
| UBS Group | 6.2k | $191.766000 | -74% | Dec 2025 |
|
| Wolverine Asset Management | 1.8k | $57.046500 | 0% | Dec 2025 |
|
| Goss Wealth Management | 1.1k | $33.017600 | 0% | Dec 2025 |
|
| Toronto-Dominion Bank | 200.00 | $5.000000 | 100% | Sep 2025 |
|
Who sold out of Sab Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LMR Partners | Sep 2025 | 540k | $13k |
| Susquehanna International | Sep 2025 | 26k | $749.607000 |
| Walleye Trading | Sep 2025 | 11k | $267.602400 |